Medrad has installed its 5,000th Stellant CT injection system since the introduction of the product just three years ago.

Medrad marked the milestone Stellant installation on May 3 at the Cardiovascular Institute of the South (CIS) Houma Clinic in Houma, La. CIS is expanding its cardiac CT practice with new 64-slice CT scanners. "We chose Stellant D for its Dual Flow option that enables management of contrast enhancement in both sides of the heart," said Ritchie Dupre, diagnostic services manager at CIS. Dual Flow has been demonstrated to improve right coronary artery visualization.

"Stellant is a tremendous product that is changing the way clinicians are looking at the human heart," said John Friel, Medrad president and CEO, who was on hand to celebrate the install. "The numerous Stellant installations are evidence of cardiac CT's value as a diagnostic tool and the leading role that Medrad plays with this emerging technology," he added.

According to the company release, even as current Stellant technology continues to prove its value, Medrad is preparing several enhancements to the product, including: Smart Flow - shown as a works-in-progress at RSNA 2005, Smart Flow provides a suggested cardiac protocol based on the individual characteristics of each patient. This customization is intended to improve enhancement and promote more efficient use of contrast agent.

Medrad's product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services.